Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1994 Aug;78(8):621–623. doi: 10.1136/bjo.78.8.621

Oral albendazole in the management of extraocular cysticercosis.

R Sihota 1, S G Honavar 1
PMCID: PMC504887  PMID: 7918290

Abstract

Surgical removal of extraocular cysticerci is fraught with complications. The effect of oral albendazole in such cases has been evaluated in a randomised, controlled, clinical trial. Of 24 ultrasonographically diagnosed, and ELISA positive cases of extraocular cysticerci, 12 received oral albendazole 15 mg/kg once daily for 1 month, while the 12 controls received a placebo. Marked clinical improvement was seen in all the cases in the treatment group at 4 weeks, with collapse of the cyst at 6 weeks (75%), and complete disappearance at 3 months (100%). No clinical or ultrasonographical change was noted in the control group. A trial of medical management with oral albendazole merits consideration in cases of extraocular cysticerci.

Full text

PDF
621

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agapejev S., Meira D. A., Barraviera B., Machado J. M., Marques P. C., Mendes R. P., Kamegasawa A., Ueda A. K. Neurocysticercosis: treatment with albendazole and dextrochloropheniramine. Trans R Soc Trop Med Hyg. 1989 May-Jun;83(3):377–383. doi: 10.1016/0035-9203(89)90509-9. [DOI] [PubMed] [Google Scholar]
  2. Alarcón F., Escalante L., Dueñas G., Montalvo M., Román M. Neurocysticercosis. Short course of treatment with albendazole. Arch Neurol. 1989 Nov;46(11):1231–1236. doi: 10.1001/archneur.1989.00520470099034. [DOI] [PubMed] [Google Scholar]
  3. Kestelyn P., Taelman H. Effect of praziquantel on intraocular cysticercosis: a case report. Br J Ophthalmol. 1985 Oct;69(10):788–790. doi: 10.1136/bjo.69.10.788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kramer L. D., Locke G. E., Byrd S. E., Daryabagi J. Cerebral cysticercosis: documentation of natural history with CT. Radiology. 1989 May;171(2):459–462. doi: 10.1148/radiology.171.2.2704811. [DOI] [PubMed] [Google Scholar]
  5. Kruger-Leite E., Jalkh A. E., Quiroz H., Schepens C. L. Intraocular cysticercosis. Am J Ophthalmol. 1985 Mar 15;99(3):252–257. doi: 10.1016/0002-9394(85)90352-6. [DOI] [PubMed] [Google Scholar]
  6. Mais F. A. A criocirurgia na cisticercose ocular. Rev Bras Oftalmol. 1969 Apr-Jun;28(2):99–103. [PubMed] [Google Scholar]
  7. Malik S. R., Gupta A. K., Choudhry S. Ocular cysticercosis. Am J Ophthalmol. 1968 Dec;66(6):1168–1171. doi: 10.1016/0002-9394(68)90829-5. [DOI] [PubMed] [Google Scholar]
  8. Moodley M., Moosa A. Treatment of neurocysticercosis: is praziquantel the new hope? Lancet. 1989 Feb 4;1(8632):262–263. doi: 10.1016/s0140-6736(89)91268-3. [DOI] [PubMed] [Google Scholar]
  9. REDDY P. S., SATYENDRAN O. M. OCULAR CYSTICERCOSIS. Am J Ophthalmol. 1964 Apr;57:664–666. doi: 10.1016/0002-9394(64)92515-2. [DOI] [PubMed] [Google Scholar]
  10. Sen D. K. Cysticercus cellulosae in the lacrimal gland, orbit, and eye lid. Acta Ophthalmol (Copenh) 1980;58(1):144–147. doi: 10.1111/j.1755-3768.1980.tb04578.x. [DOI] [PubMed] [Google Scholar]
  11. Sotelo J., Escobedo F., Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. 1988 May;45(5):532–534. doi: 10.1001/archneur.1988.00520290064015. [DOI] [PubMed] [Google Scholar]
  12. Sotelo J., Guerrero V., Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med. 1985 Mar;145(3):442–445. [PubMed] [Google Scholar]
  13. Sotelo J., Penagos P., Escobedo F., Del Brutto O. H. Short course of albendazole therapy for neurocysticercosis. Arch Neurol. 1988 Oct;45(10):1130–1133. doi: 10.1001/archneur.1988.00520340084017. [DOI] [PubMed] [Google Scholar]
  14. Sotelo J., del Brutto O. H., Penagos P., Escobedo F., Torres B., Rodriguez-Carbajal J., Rubio-Donnadieu F. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J Neurol. 1990 Apr;237(2):69–72. doi: 10.1007/BF00314663. [DOI] [PubMed] [Google Scholar]
  15. del Brutto O. H., Sotelo J. Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report. J Neurosurg. 1990 May;72(5):816–817. doi: 10.3171/jns.1990.72.5.0816. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES